Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IPOPEMA Securities's EBIT per Share for the
three
months ended in Mar. 2026 was zł0.27.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł1.39.
During the past 12 months, the average EBIT per Share Growth Rate of IPOPEMA Securities was 282.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 45.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -8.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 22.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for IPOPEMA Securities's EBIT per Share or its related term are showing as below:
WAR:IPE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -70.9 Med: -8.1 Max: 378.7
Current: 45.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of IPOPEMA Securities was 378.70% per year. The lowest was -70.90% per year. And the median was -8.10% per year.
WAR:IPE's 3-Year EBIT Growth Rate is ranked better than 79.3% of 488
companies
in the Capital Markets industry
Industry Median: 11.85
vs WAR:IPE: 45.20
IPOPEMA Securities (WAR:IPE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
IPOPEMA Securities EBIT per Share Related Terms
IPOPEMA Securities EBIT per Share Historical Data
* Premium members only.
The historical data trend for IPOPEMA Securities's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł1.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPOPEMA Securities (WAR:IPE) has a EBIT per Share of zł1.39 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IPOPEMA Securities and its competitors. According to the industry distribution chart, IPOPEMA Securities ranks #101 out of 488 companies in the Capital Markets industry, placing it in the top 20.7%.
Is IPOPEMA Securities' EBIT per Share too high?
IPOPEMA Securities' current EBIT per Share is zł1.39. Based on the distribution chart, IPOPEMA Securities ranks #101 out of 488 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, IPOPEMA Securities has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' EBIT per Share compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #101 out of 488 companies for EBIT per Share. This places IPOPEMA Securities in the top 21% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Capital Markets company?
The median EBIT per Share among Capital Markets companies is 11.85, based on 488 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on IPOPEMA Securities and its competitors. For the Capital Markets industry, the median EBIT per Share is 11.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IPOPEMA Securities's current EBIT per Share is zł1.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.62, compared to a current price of zł7.30 — trading 101.7% above its estimated fair value. The current EBIT per Share is zł1.39. IPOPEMA Securities' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current EBIT per Share is zł1.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł7.30 is trading 101.7% above its estimated GF Value™ of zł3.62.
GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.
Key valuation signals for WAR:IPE:
EBIT per Share: zł1.39
GF Value™: zł3.62 vs. price of zł7.30 (101.7% above fair value)
No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
58GF Score
Get the complete analysis for WAR:IPE
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:IPE has been successfully added to your 
